In this study, healthy male volunteers will receive a single intravenous administration of either PF-05280014 or trastuzumab (United States) or trastuzumab (European Union)
If I were a patient, I would demand trastuzumab U.S. Would have concerns over stability of trastuzumab EU.
Market Data 
Markets 
AI
